<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">717320</article-id><article-id pub-id-type="doi">10.18565/pharmateca.2026.4.249-258</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Endocrinology</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Эндокринология</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Microcirculation and nadh fluorescence parameters in the skin of patients with overt hypothyroidism and their dynamics after achieving euthyroidism</article-title><trans-title-group xml:lang="ru"><trans-title>Параметры микроциркуляции и флуоресценции НАДН в коже у пациентов с явным гипотиреозом и их динамика после достижения эутиреоза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0069-1692</contrib-id><name-alternatives><name xml:lang="en"><surname>Ryzhkova</surname><given-names>Ekaterina G.</given-names></name><name xml:lang="ru"><surname>Рыжкова</surname><given-names>Екатерина Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate Student, Department of Endocrinology and Metabolic Health, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>аспирант кафедры эндокринологии и метаболического здоровья Института клинической медицины им. Н.В. Склифосовского</p></bio><email>e.g.ryzhkova@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1500-1586</contrib-id><name-alternatives><name xml:lang="en"><surname>Morgunova</surname><given-names>T. B.</given-names></name><name xml:lang="ru"><surname>Моргунова</surname><given-names>Т. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Associate Professor, Endocrinologist</p></bio><bio xml:lang="ru"><p>к.м.н., доцент, врач-эндокринолог</p></bio><email>tanmorgun@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3026-6315</contrib-id><name-alternatives><name xml:lang="en"><surname>Fadeev</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Фадеев</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Corresponding Member of the Russian Academy of Sciences, Professor, Department of Internal Medicine, Faculty of Fundamental Medicine</p></bio><bio xml:lang="ru"><p>член-корр. РАН, профессор кафедры внутренних болезней факультета фундаментальной медицины МНОИ</p></bio><email>walfad@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Professorial Clinic of Endocrinology and Diabetes</institution></aff><aff><institution xml:lang="ru">ООО «Профессорская клиника эндокринологии и диабета»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></pub-date><pub-date date-type="collection"><year>2026</year></pub-date><volume>33</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>249</fpage><lpage>258</lpage><history><date date-type="received" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, ООО «Бионика Медиа»</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://journals.eco-vector.com/2073-4034/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/717320">https://journals.eco-vector.com/2073-4034/article/view/717320</self-uri><abstract xml:lang="en"><p><bold>Background: </bold>Hypothyroidism (HT) is associated with cardiovascular and metabolic disorders, which in some cases do not improve with levothyroxine sodium (LT4) replacement therapy.</p> <p><bold>Objective: </bold>Evaluation of microcirculation and reduced nicotinamide adenine dinucleotide (NADH) fluorescence in the skin of patients with newly diagnosed overt HT before and after achieving euthyroidism with LT4.</p> <p><bold>Materials and methods: </bold>Lipid profiles, complete blood counts, interleukin-6 (IL-6) levels, microcirculation, and NADH fluorescence amplitude (AFNADH) were assessed in forearm skin of 50 healthy volunteers and 14 patients with overt HT at rest, upon cooling to 10°C, and upon heating to 35°C and 42°C. The standard deviation (σ) and blood flow variation coefficient (Kv) were calculated, and wavelet analysis was used to determine the amplitudes of microcirculation fluctuations in the neurogenic (An), myogenic (Am), respiratory (Ar), and cardic (Ac) ranges.</p> <p><bold>Results: </bold>In overt hyperthermia, the microcirculation index upon heating to 42°C, Aм, Aс, and σ were lower than in healthy volunteers. No differences were found in other microcirculation parameters, nor in AFNADH at rest, upon cooling and heating to 35°C. After achieving euthyroidism, no statistically significant changes in microcirculation parameters or AFNADH were observed. During hyperthermia, levels of total cholesterol (TC), low-density lipoproteins (LDL), triglycerides, IL-6, and erythrocyte distribution width (RDW) were higher than in healthy volunteers. Positive changes in these parameters were noted after treatment.</p> <p><bold>Conclusion: </bold>Disturbances in cutaneous microcirculation during hyperthermia are manifested by a decrease in peak hyperemia upon heating to 42°C and a reduction in microcirculation variability due to a decrease in Aм and Aс, which persists after achieving euthyroidism. These changes are associated with dyslipidemia, increased IL-6, and RDW, with subsequent improvement during treatment. AFNADH parameters do not differ between patients with HT and healthy volunteers and do not change during treatment.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность:</bold> Гипотиреоз (ГТ) связан с сердечно-сосудистыми и метаболическими нарушениями, которые в ряде случаев не восстанавливаются на фоне заместительной терапии левотироксином натрия (LT4).</p> <p><bold>Цель исследования: </bold>оценить микроциркуляцию и флуоресценцию восстановленного никотинамидадениндинуклеотида (НАДН) в коже у пациентов с впервые выявленным явным ГТ до и после достижения эутиреоза на фоне LT4.</p> <p><bold>Материалы и методы: </bold>У 50 здоровых добровольцев и 14 пациентов с явным ГТ оценивали липидный профиль, показатели общего анализа крови, уровень интерлейкина-6 (ИЛ-6), микроциркуляцию и амплитуду флуоресценции НАДН (AFНАДН) в коже предплечья в покое, при охлаждении до 10 °C, нагревании до 35 и 42 °C. Рассчитывали среднеквадратичное отклонение (σ), коэффициент вариации кровотока (Kv) и методом вейвлет-анализа определяли амплитуды колебаний микроциркуляции в нейрогенном (Aн), миогенном (Aм), дыхательном (Ад) и пульсовом (Aсерд) диапазонах.</p> <p><bold>Результаты: </bold>При явном ГТ показатель микроциркуляции при нагревании до 42 °C, Aм, Aсерд и σ были ниже, чем у здоровых добровольцев. По другим параметрам микроциркуляции, а также AFНАДН в покое при охлаждении и нагревании до 35 °C не выявлено различий. После достижения эутиреоза не выявлено статистически значимой динамики параметров микроциркуляции и AFНАДН. При ГТ уровни общего холестерина (ХС), липопротеидов низкой плотности (ЛПНП), триглицеридов, ИЛ-6 и ширины распределения эритроцитов (RDW) были выше, чем у здоровых. После лечения отмечена положительная динамика этих параметров.</p> <p><bold>Выводы:</bold> Нарушения кожной микроциркуляции при ГТ проявляются уменьшением пиковой гиперемии при нагревании до 42 °C и снижением вариабельности микроциркуляции за счет уменьшения Aм и Aсерд, сохраняющимися после достижения эутиреоза. Эти изменения сочетаются с дислипидемией, повышением ИЛ-6 и RDW, с последующей положительной динамикой на фоне лечения. Параметры AFНАДН не различаются между пациентами с ГТ и здоровыми добровольцами, а также не изменяются на фоне лечения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>hypothyroidism</kwd><kwd>levothyroxine</kwd><kwd>skin perfusion</kwd><kwd>intracellular metabolism</kwd><kwd>temperature testing</kwd><kwd>interleukin-6</kwd><kwd>lipid profile</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гипотиреоз</kwd><kwd>левотироксин</kwd><kwd>кожная перфузия</kwd><kwd>внутриклеточный метаболизм</kwd><kwd>температурная проба</kwd><kwd>интерлейкин-6</kwd><kwd>липидный профиль</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Волкова А.Р., Халимов Ю.Ш., Дыгун О.Д. и др. Субклинический гипотиреоз и сердечно-сосудистые заболевания: патогенетические механизмы и клинические последствия. Медицинский совет. 2025;(5):107–12. [Volkova A.R., Khalimov Yu.Sh., Dygun O.D., et al. Subclinical hypothyroidism and cardiovascular diseases: Pathogenetic mechanisms and clinical implications. Meditsinskiy Sovet. 2025;(5):107–12. (In Russ.)]. https://doi.org/10.21518/ms2025-160</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Бирюкова Е.В., Абрамова А.Д. Гипотиреоз: от диагностики к успеху терапии. Consilium Medicum. 2025;27(4):210–7. [Biryukova E.V., Abramova A.D. Hypothyroidism: from diagnosis to therapy success. A review. Consilium Medicum. 2025;27(4):210–7. (In Russ.)]. https://doi.org/10.26442/20751753.2025.4.203294</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Taylor P.N., Medici M.M., Hubalewska-Dydejczyk A., Boelaert K. Hypothyroidism. Lancet. 2024;404(10460):1347–64. https://doi.org/10.1016/S0140-6736(24)01614-3</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Thvilum M., Lind S.M., Ebbehoj E., et al. Quality of life in patients with overt hypothyroidism: a systematic review. Eur J Endocrinol. 2025;193(3):S26–35. https://doi.org/10.1093/ejendo/lvaf179</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Sharma S., Tobin V., Vas P.R.J., Rayman G. The LDIFLARE and CCM Methods Demonstrate Early Nerve Fiber Abnormalities in Untreated Hypothyroidism: A Prospective Study. J Clin Endocrinol Metab. 2018;103(8):3094–102. https://doi.org/10.1210/jc.2018-00671</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Кулабухова И.С., Елисеева Л.Н., Оранский С.П. и др. Изменения микрососудистого статуса у пациентов с первичным гипотиреозом. Вестник современной клинической медицины. 2018;11(1):29–33. doi:10.20969/VSKM.2018.11(1).29-33 [Kulabukhova I.S., Eliseyeva L.N., Oranskiy S.P. et al. Microvascular status changes in patients with primary hypothyroidism. Vestnik sovremennoi klinicheskoi meditsiny. 2018;11(1):29–33. (In Russ.)]. https://doi.org/10.20969/VSKM</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kozacz A., Assis G.G.D., Sanocka U., Ziemba A.W. Standard hypothyroid treatment did not restore proper metabolic response to carbohydrate. Endocrine. 2021;71(1):96–103. https://doi.org/10.1007/s12020-020-02334-0</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hou L.Y., Li X., Zhang G.Q., et al. Transiently impaired endothelial function during thyroid hormone withdrawal in differentiated thyroid cancer patients. Front Endocrinol. (Lausanne). 2023;14:1164789. https://doi.org/10.3389/fendo.2023.1164789</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bernardi S., Grillo A., Antonello R.M., et al. Meta-analysis on the Association Between Thyroid Hormone Disorders and Arterial Stiffness. J Endocrine Soc. 2022;6(4):bvac016. https://doi.org/10.1210/jendso/bvac016</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Soto-García A.J., Elizondo-Riojas G., Rodriguez-Gutiérrez R., et al. Carotid Intima-Media Thickness in Patients with Subclinical Hypothyroidism: A Prospective Controlled Study. Clin Invest Med. 2021;44(4):E39–45. https://doi.org/10.25011/cim.v44i4.37139</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Alexander Y., Osto E., Schmidt-Trucksäss A., et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis. Cardiovasc Res. 2021;117(1):29–42. https://doi.org/10.1093/cvr/cvaa085</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Xu C., Sellke F.W., Abid M.R. Assessments of microvascular function in organ systems. Am J Physiol Heart Circ Physiol. 2022;322(6):H891–905. https://doi.org/10.1152/ajpheart.00589.2021</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Cracowski J.L., Roustit M. Human Skin Microcirculation. Compr Physiol. 2020;10(3):1105–54. https://doi.org/10.1002/cphy.c190008</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Klein I., Ojamaa K. Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res. 2001;88(3):260–1. https://doi.org/10.1161/01.res.88.3.260</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Дунаев А.В. Мультимодальная оптическая диагностика микроциркуляторно-тканевых систем организма человека: монография. Старый Оскол, 2022. 440 с.: ил. [Dunaev A.V. Multimodal optical diagnostics of microcirculatory tissue systems of the human body: monograph. Staryi Oskol, 2022. 440 p. (In Russ.)].</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Dremin V.V., Kozlov I.O., Zherebtsov E.A., et al. The capabilities of laser Doppler flowmetry in assessment of lymph and blood microcirculation. Regional blood circulation and microcirculation. 2017;16(4):42–9. https://doi.org/10.24884/1682-6655-2017-16-4-42-49</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Ryzhkova E., Morgunova T., Potapova E., et al. Fluorescence Spectroscopy With Temperature Functional Tests in the Assessment of Markers of Intracellular Energy Metabolism: Spatial Heterogeneity and Reproducibility of Measurements. J Biophoton. 2024;17(10):e202400294. https://doi.org/10.1002/jbio.202400294</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Minson C.T. Thermal provocation to evaluate microvascular reactivity in human skin. J Appl Physiol. 2010;109(4):1239–46. https://doi.org/10.1152/japplphysiol.00414.2010</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pazos-Moura C.C., Moura E.G., Breitenbach M.M.D., Bouskela E. Nailfold Capillaroscopy in Hypothyroidism and Hyperthyroidism: Blood Flow Velocity During Rest and Postocclusive Reactive Hyperemia. Angiology. 1998;49(6):471–6. https://doi.org/10.1177/000331979804900608</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Weiss M., Milman B., Rosen B., Zimlichman R. Quantitation of thyroid hormone effect on skin perfusion by laser Doppler flowmetry. J Clin Endocrinol Metab. 1993;76(3):680–2. https://doi.org/10.1210/jcem.76.3.8445026</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Клинические рекомендации. Гипотиреоз. Общественная организация «Российская ассоциация эндокринологов». Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 531_4. 2024. Доступ: https://cr.minzdrav.gov.ru/view-cr/531_4 (дата обращения: 25.01.2026). [Clinical guidelines. Hypothyroidism. Public organization «Russian Association of Endocrinologists» Rubricator of clinical guidelines of the Ministry of Health of the Russian Federation. 2024. ID: 531_4. 2024. Access: https://cr.minzdrav.gov.ru/view-cr/531_4 (date of access: 25.01.2026). (In Russ.)].</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Крупаткин А.И., Сидоров В.В. Функциональная диагностика состояния микроциркуляторно-тканевых систем: Колебания, информация, нелинейность (Руководство для врачей). M., 2013. 496 с. [Krupatkin A., Sidorov V. Functional diagnostics of microcirculatory-tissue systems: oscillations, information, nonlinearity: a guide for doctors. M., 2013. 496 p. (In Russ.)].</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Mihor A., Gergar M., Gaberšček S., Lenasi H. Skin microvascular reactivity in patients with hypothyroidism. Clin Hemorheol Microcirc. 2016;64(1):105–14. https://doi.org/10.3233/CH-162062</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Roberts K.A., van Gent T., Hopkins N.D., et al. Reproducibility of four frequently used local heating protocols to assess cutaneous microvascular function. Microvasc Res. 2017;112:65–71. https://doi.org/10.1016/j.mvr.2017.03.005</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Johnson J.M., Minson C.T., Kellogg D.L. Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation. Compr Physiol. 2014;4(1):33–89. https://doi.org/10.1002/cphy.c130015</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Johnson J.M. Mechanisms of vasoconstriction with direct skin cooling in humans. Am J Physiol Heart Circ Physiol. 2007;292(4):H1690–1. https://doi.org/10.1152/ajpheart.00048.2007</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Prakash K., Hamid P. Thyroid Hormone Resistance Syndrome: From Molecular Mechanisms to Its Potential Contribution to Hypertension. Cureus. 2023;15(12):e49913. https://doi.org/10.7759/cureus.49913</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Gluvic Z.M., Obradovic M.M., Sudar-Milovanovic E.M., et al. Regulation of nitric oxide production in hypothyroidism. Biomed Pharmacother. 2020;124:109881. https://doi.org/10.1016/j.biopha.2020.109881</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Heymsfield S.B., Smith B., Dahle J., et al. Resting Energy Expenditure: From Cellular to Whole‐Body Level, a Mechanistic Historical Perspective. Obesity. 2021;29(3):500–11. https://doi.org/10.1002/oby.23090</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Izkhakov E., Vaisman N., Barnes S., et al. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma. Thyroid. 2019;29(8):1044–51. https://doi.org/10.1089/thy.2018.0483</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Cioffi F., Giacco A., Goglia F., Silvestri E. Bioenergetic Aspects of Mitochondrial Actions of Thyroid Hormones. Cells. 2022;11(6):997. Doi: 10.3390/cells11060997</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Eom Y.S., Wilson J.R., Bernet V.J. Links between Thyroid Disorders and Glucose Homeostasis. Diabetes Metab J. 2022;46(2):239–56. https://doi.org/10.4093/dmj.2022.0013</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Rossi M., Carpi A., Di Maria C., et al. Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res. 2009;58(1):39–47. https://doi.org/10.33549/physiolres.931351</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Ference B.A., Ginsberg H.N., Graham I., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72. https://doi.org/10.1093/eurheartj/ehx144</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Ketelhuth D.F.J., Bäck M. Myeloid-specific interleukin-6 response: from vascular effects to the potential for novel personalized medicines. Eur Heart J Open. 2024;4(4):oeae047. https://doi.org/10.1093/ehjopen/oeae047</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Li R., He T., Xing Z., et al. The immune system in Hashimoto’s thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction. Autoimmun Rev. 2025;24(6):103783. https://doi.org/10.1016/j.autrev.2025.103783</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Berta D.M., Gelaw Y., Shiferaw E., et al. Hematological Abnormalities and Associated Factors Among Patients with Hypothyroidism at the University of Gondar Comprehensive Specialized Hospital. J Blood Med. 2024;15:157–69. https://doi.org/10.2147/JBM.S453015</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Uydu H.A., Bostan M., Atak M., et al. Cholesterol forms and traditional lipid profile for projection of atherogenic dyslipidemia: lipoprotein subfractions and erythrocyte membrane cholesterol. J Membr Biol. 2014;247(2):127–34. https://doi.org/10.1007/s00232-013-9611-2</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Lichtman M.A. Red cell distribution width as a bellwether of prognosis. Blood Cells Mol Dis. 2024 Nov;109:102884. https://doi.org/10.1016/j.bcmd.2024.102884</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Shivaprasad C., Rakesh B., Anish K., et al. Impairment of health-related quality of life among Indian patients with hypothyroidism. Indian J Endocr Metab. 2018;22(3):335. https://doi.org/10.4103/ijem.IJEM_702_17</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Изосимова А.В., Можеров А.М., Ширманова М.В. и др. FLIM-имиджинг автофлуоресценции НАД(Ф)Н Т-клеток в лимфатических узлах для оценки эффективности анти-CTLA-4-иммунотерапии. Современные технологии в медицине. 2023;15(3):5. [Izosimova A.V., Mozherov A.M., Shirmanova M.V., et al. Fluorescence lifetime imaging of NAD(P)H T cells autofluorescence in the lymphatic nodes to assess the effectiveness of anti-CTLA-4 immunotherapy. Sovremennye Tekhnologii v Meditsine. 2023;15(3):5. (In Russ.)]. https://doi.org/10.17691/stm2023.15.3.01</mixed-citation></ref></ref-list></back></article>
